Home / MOTS-c calculator
MOTS-c reconstitution calculator
MOTS-c has no FDA-approved product and no established human dose, so this page gives no dose. It does the math for whatever your prescriber specified: enter the mg on your vial, the water you add and the dose, or use the table to see how much each syringe unit holds.
How much MOTS-c is in each unit
mcg per unit (0.01 mL) on a U-100 syringe. Vial sizes are examples; read the mg on your own vial. Not FDA-approved; no human data for native MOTS-c.
| Water | 5 mg vial | 10 mg vial |
|---|---|---|
| 1 mL | 50 mcg | 100 mcg |
| 2 mL | 25 mcg | 50 mcg |
| 3 mL | 16.7 mcg | 33.3 mcg |
| 5 mL | 10 mcg | 20 mcg |
To turn a prescribed dose into units: dose in mcg ÷ mcg per unit. The calculator above does it and checks it fits your syringe. Evidence and US status: MOTS-c reference page.
Units are not mg. "10 units" on a syringe is 0.1 mL. How many mg that holds depends on how the vial was mixed. If a prescription is written in units, confirm the concentration it assumes.
Questions
- How many mcg is 1 unit of MOTS-c?
- It depends only on the mix. Each unit is 0.01 mL, so it holds (mg in vial ÷ mL of water) × 10 mcg. A 5 mg vial with 2 mL of water holds 25 mcg per unit.
- What is the dose of MOTS-c?
- There is no established human dose. Native MOTS-c: no human exposure data (FDA). A modified analogue, CB4211, was tested at 25 mg daily for 4 weeks in 20 people with obesity and fatty liver. That is a different molecule.
- Is MOTS-c FDA-approved?
- Not approved by the FDA for any use. FDA removed it from its "significant safety risk" compounding list in April 2026 after the nomination was withdrawn, and an FDA advisory committee voted in favor of allowing pharmacy compounding in July 2026, against the recommendation of FDA staff. On October 30, 2026, HHS published a draft policy saying it does not intend to take enforcement action against state-licensed pharmacies that compound it for a named patient with a prescription, under listed conditions and routes. That is not an FDA approval and says nothing about safety or effectiveness. The draft policy names injection under the skin or into muscle.
Sources
- FDA: Certain bulk drug substances for compounding that may present significant safety risks
- Federal Register (public inspection) 2026-07361: peptide category changes
- PharmExec: FDA advisory committee votes to loosen restrictions on peptides (Jul 2026)
- FDA 510(k) K212499: BD insulin syringes for U-100 insulin
Last checked 2026-11-16. How we pick and check sources: methodology.